Literature DB >> 18364015

Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access.

Jeffrey Hoggard1, Theodore Saad, Don Schon, Thomas M Vesely, Tim Royer.   

Abstract

At the time of hemodialysis vascular access evaluation, many chronic kidney disease patients already have iatrogenic injury to their veins which impedes the surgical construction of an arteriovenous fistula (AVF). Achieving the important goal of a greater prevalence of arteriovenous fistulae in the US hemodialysis population will require identification of those patients prior to reaching end-stage renal disease and an educational and procedural system for preserving their veins.

Entities:  

Mesh:

Year:  2008        PMID: 18364015     DOI: 10.1111/j.1525-139X.2008.00421.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  18 in total

1.  Medical alert bracelet: an effective way to preserve veins for future dialysis vascular access in patients with chronic kidney disease.

Authors:  Tushar Vachharajani
Journal:  Medscape J Med       Date:  2009-01-02

2.  A single institutional experience of conversion of non-tunneled to tunneled hemodialysis catheters: a comparison to de novo placement.

Authors:  Sunil Kumar Bajaj; Joseph Ciacci; Matthias Kirsch; John D Ebersole
Journal:  Int Urol Nephrol       Date:  2013-07-23       Impact factor: 2.370

3.  Eliminating Infections in the ICU: CLABSI.

Authors:  Asad Latif; Muhammad Sohail Halim; Peter J Pronovost
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

4.  Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients.

Authors:  Mireille El Ters; Gregory J Schears; Sandra J Taler; Amy W Williams; Robert C Albright; Bernice M Jenson; Amy L Mahon; Andrew H Stockland; Sanjay Misra; Scott L Nyberg; Andrew D Rule; Marie C Hogan
Journal:  Am J Kidney Dis       Date:  2012-06-15       Impact factor: 8.860

5.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

Review 6.  Perioperative management of patients undergoing thoracic endovascular repair.

Authors:  Subhasis Chatterjee; Ourania Preventza; Vicente Orozco-Sevilla; Joseph S Coselli
Journal:  Ann Cardiothorac Surg       Date:  2021-11

7.  Neuromuscular electrostimulation: a new therapeutic option to improve radio-cephalic arteriovenous fistula maturation in end-stage chronic kidney disease patients.

Authors:  Lucia Martinez; Vicent Esteve; Montserrat Yeste; Vicent Artigas; Secundino Llagostera
Journal:  Int Urol Nephrol       Date:  2017-04-21       Impact factor: 2.370

8.  Patterns and Predictors of Short-Term Peripherally Inserted Central Catheter Use: A Multicenter Prospective Cohort Study.

Authors:  David Paje; Anna Conlon; Scott Kaatz; Lakshmi Swaminathan; Tanya Boldenow; Steven J Bernstein; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2018-02       Impact factor: 2.960

9.  Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

Authors:  Rita L McGill; Robin Ruthazer; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

10.  Forearm loop arteriovenous grafts preserve and may create new upper arm access sites.

Authors:  Nathan K Itoga; Whitt Virgin-Downy; Matthew W Mell
Journal:  J Vasc Access       Date:  2019-04-22       Impact factor: 2.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.